Literature DB >> 16355015

Hypertension and the metabolic syndrome.

Stephen A Morse1, Rubin Zhang, Vashu Thakur, Efrain Reisin.   

Abstract

The cause of hypertension in the metabolic syndrome is complex and multifactorial and all of the elements of the metabolic syndrome, including obesity, insulin resistance, and the characteristic dyslipidemia probably are involved in mediating changes ultimately resulting in hypertension and modifying its course. Of these elements, obesity may play the most important and pivotal role in creating the conditions that lead to hypertension in the metabolic syndrome. This is not to say that the other elements of the syndrome are less important, and, as we gain more insight into the processes involved, we should be able to better manage the disease and tailor our therapeutic interventions appropriately.

Entities:  

Mesh:

Year:  2005        PMID: 16355015     DOI: 10.1097/00000441-200512000-00008

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  13 in total

Review 1.  The impacts of obesity on the cardiovascular and renal systems: cascade of events and therapeutic approaches.

Authors:  Zohreh Soltani; Vaughn Washco; Stephen Morse; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2015-02       Impact factor: 5.369

Review 2.  Insulin resistance and atherosclerosis.

Authors:  Clay F Semenkovich
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

Review 3.  Effects of glycine on metabolic syndrome components: a review.

Authors:  M Imenshahidi; H Hossenzadeh
Journal:  J Endocrinol Invest       Date:  2022-01-11       Impact factor: 4.256

4.  Impact of Adiposity on Incident Hypertension Is Modified by Insulin Resistance in Adults: Longitudinal Observation From the Bogalusa Heart Study.

Authors:  Tao Zhang; Huijie Zhang; Shengxu Li; Ying Li; Yaozhong Liu; Camilo Fernandez; Emily Harville; Lydia Bazzano; Jiang He; Wei Chen
Journal:  Hypertension       Date:  2015-11-16       Impact factor: 10.190

5.  Factors associated with the prevalence of hypertension in the southeastern United States: insights from 69,211 blacks and whites in the Southern Community Cohort Study.

Authors:  Uchechukwu K A Sampson; Todd L Edwards; Eiman Jahangir; Heather Munro; Minaba Wariboko; Mariam G Wassef; Sergio Fazio; George A Mensah; Edmond K Kabagambe; William J Blot; Loren Lipworth
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-12-23

Review 6.  Obesity, sleep apnea, aldosterone, and hypertension.

Authors:  Theodore L Goodfriend
Journal:  Curr Hypertens Rep       Date:  2008-06       Impact factor: 5.369

Review 7.  Operative risk factors in the metabolic syndrome: is it lipids and high blood pressure or are there direct vascular effects of insulin resistance and obesity?

Authors:  Olavi Ukkola
Journal:  Curr Cardiol Rep       Date:  2006-11       Impact factor: 3.955

Review 8.  Cardiovascular dysfunction in obesity and new diagnostic imaging techniques: the role of noninvasive image methods.

Authors:  José Augusto A Barbosa; Alexandre B Rodrigues; Cleonice Carvalho C Mota; Márcia M Barbosa; Ana C Simões e Silva
Journal:  Vasc Health Risk Manag       Date:  2011-05-10

Review 9.  A comprehensive review on metabolic syndrome.

Authors:  Jaspinder Kaur
Journal:  Cardiol Res Pract       Date:  2014-03-11       Impact factor: 1.866

10.  Reevaluation of the prevalence of metabolic syndrome in an urban area of Turkey.

Authors:  Mehmet Emre Atabek; Beray Selver Eklioğlu; Nesibe Akyürek
Journal:  J Clin Res Pediatr Endocrinol       Date:  2013-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.